Skip to main content

Atypical APIs: A Hidden Source of Audit Risk

VYCERIN® API Glycerin, USP on the DMF, Built for Audit Readiness

Where the Compliance Gap Occurs

When glycerin functions as an active pharmaceutical ingredient (API), it should be sourced, controlled, and documented to API-level standards. However, many glycerin supply chains were originally built around excipient-grade expectations. NF and USP compliance are critical foundations, but when glycerin functions as an API, manufacturers often look for deeper alignment around traceability, documentation, and API-oriented quality support.

Reduce compliance risk with glycerin specifically designed for active-use pharmaceutical applications. Vantage’s VYCERIN® API Glycerin, USP is listed on the DMF (Drug Master File), manufactured to full ICH Q7 standards, and designed to support FDA monograph drug applications where glycerin functions as an active ingredient.

When Glycerin Is an API — It Should Be Managed Like One

While front-of-the-label claims are designed for consumer communication – highlighting product benefits and intended use – the Drug Facts panel is where FDA-regulated therapeutic claims are formally defined.

Across multiple FDA monographs, glycerin is defined as an active pharmaceutical ingredient, contributing directly to the product’s intended therapeutic effect. That distinction matters. In these applications, glycerin is functioning within the FDA’s active pharmaceutical framework – not as an excipient providing formulation support.

FDA Monographs with Glycerin Parameters include:
  • M007: Laxative Drugs – as a hyperosmotic laxative in suppositories & enemas
  • M015: Anorectal Drugs – as a humectant & skin protectant in hemorrhoid creams
  • M016: Skin Protectant Drugs – as a humectant & skin protectant in dermatological & lip treatments
  • M022: Oral Healthcare Drugs – as an oral dumulcent in throat sprays

Where Compliance Gaps Can Occur

When an ingredient functions as an active pharmaceutical ingredient, expectations shift accordingly and they will be evaluated through an API-level regulatory and quality lens.

Using glycerin supported by a Drug Master File (DMF) helps strengthen audit readiness by providing the documentation, regulatory support, and manufacturing transparency expected during filings, inspections, and quality reviews.

Gaps can emerge in areas critical to audit readiness, including:
  • Documentation – Insufficient API-level regulatory support
  • Traceability – Limited visibility across multi-tier supply chains
  • Supplier qualification – Controls not aligned with API expectations
  • Change management – Less rigorous oversight compared to API standards

Improve Audit Readiness by aligning use with regulatory expectations — VYCERIN® API Glycerin, USP, Supported by a Drug Master File (DMF)

To reduce audit risk, it is critical that ingredient selection aligns with how the material functions in the formulation. When glycerin is used as an active ingredient, selecting an API-grade, DMF-listed material includes:

  • DMF listing to simplify regulatory documentation & inspections (pre-established regulatory framework)
  • API-aligned manufacturing controls – specifications, stability data, impurity profiles
  • Full end-to-end traceability
  • Direct manufacturer supply for streamlined documentation continuity & faster service
  • Faster, more confident audit responses

Close the gap between excipient-based supply and API-level expectations, strengthen audit readiness, and reduce the burden on regulatory and quality teams during inspections with VYCERIN API Glycerin, USP (DMF #040171)

How Can We Support Your Vision?

Contact us
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.